Back Article

  • Brummelkamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science, 2002, 19; 296(5567): 550-553.

  • Bustin S A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays[J]. J Mol Endocrinol, 2000, 25(): 169-193. doi: 10.1677/jme.0.0250169

  • Chen L, Borozan I, Feld J. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection[J]. Gastroen-terology, 2005, 128(): 1437-1444. doi: 10.1053/j.gastro.2005.01.059

  • Der S D, Zhou A, Williams B R. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays[J]. Proc Natl Acad Sci USA, 1998, 95(): 15623-15628. doi: 10.1073/pnas.95.26.15623

  • Farrell P J, Broeze R J, Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells[J]. Nature, 1979, 279(): 523-525. doi: 10.1038/279523a0

  • Giannakopoulos N V, Luo J K, Papov V. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells[J]. Biochem Biophys Res Commun, 2005, 336(): 496-506. doi: 10.1016/j.bbrc.2005.08.132

  • Guidotti L G, Chisari F V. Noncytolytic control of viral infections by the innate and adaptive immune response[J]. Annu Rev Immunol, 2001, 19(): 65-91. doi: 10.1146/annurev.immunol.19.1.65

  • Hu J, Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase[J]. Proc Natl Acad Sci USA, 1996, 93(): 1060-1064. doi: 10.1073/pnas.93.3.1060

  • Hu L H, Chen F H, Li Y R. Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer[J]. World J Gastroenterol, 2004, 10(23): 3514-3517. doi: 10.3748/wjg.v10.i23.3514

  • Kunzi M S, Pitha P M. Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication[J]. J Interferon Cytokine Res, 1996, 16(): 919-927. doi: 10.1089/jir.1996.16.919

  • Lenschow D J, Giannakopoulos N V, Gunn L J. Identification of interferonstimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo[J]. J Virol, 2005, 79(): 13974-13983. doi: 10.1128/JVI.79.22.13974-13983.2005

  • Malakhov M P, Malakhova O A, Kim K I. UBP43 (UBP43) specifically removes ISG15 from con-jugated proteins[J]. J Biol Chem, 2002, 277(): 9976-9981. doi: 10.1074/jbc.M109078200

  • Malakhova O, Malakhov M, Hetherington C. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3[J]. J Biol Chem, 2002, 277(): 14703-14711. doi: 10.1074/jbc.M111527200

  • Malakhova O A, Yan M, Malakhov M P. Protein ISGylation modulates the JAK-STAT signaling pathway[J]. Genes Dev, 2003, 17(): 455-460. doi: 10.1101/gad.1056303

  • Okumura A, Lu G, Pitha-Rowe I. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15[J]. Proc Natl Acad Sci USA, 2006, 103(): 1440-1445. doi: 10.1073/pnas.0510518103

  • Ritchie K J, Hahn C S, Kim K I. Role of ISG15 protease UBP43 (UBP43) in innate immunity to viral infection[J]. Nat Med, 2004, 10(): 1374-1378. doi: 10.1038/nm1133

  • Zhao C, Denison C, Huibregtse J M. Human ISG15 conjugation targets both IFN-induced and constitu-tively expressed proteins functioning in diverse cellular pathways[J]. Proc Natl Acad Sci USA, 2005, 102(): 10200-10205. doi: 10.1073/pnas.0504754102